» Articles » PMID: 26307393

Epigenetic Downregulated ITGBL1 Promotes Non-small Cell Lung Cancer Cell Invasion Through Wnt/PCP Signaling

Overview
Journal Tumour Biol
Publisher Sage Publications
Specialty Oncology
Date 2015 Aug 27
PMID 26307393
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Integrin, beta-like 1 (ITGBL1), is a β-integrin-related extracellular matrix protein which contains ten EGF-like repeats domain. Surprisingly, we screen Oncomine Database and found that ITGBL1 is more commonly downregulated in non-small cell lung cancer (NSCLC) tissues, and the result reminds us to explore its significance in NSCLC. Thus, we retrieved DRUGSURV Database and found that downregulated ITGBL1 predicts a poor prognosis of patients. These results provided us the clues that ITGBL1 might be a tumor suppressor in NSCLC. However, the biological functions of ITGBL1 have not been reported to date. In the current study, we surprisingly found that knockdown of ITGBL1 in NSCLC cell lines could promote cancer cell migration and invasion. Furthermore, recombinant ITGBL1 protein-treated cancer cell could inhibit cell migration and invasion. These results suggested that ITGBL1 plays a suppressive role in NSCLC progression. We further found that the downregulation of ITGBL1 might result from highly expressed miR-576-5p in NSCLC tissues, and the activity of Wnt/PCP signaling was enhanced when the level of ITGBL1 was inhibited. In conclusion, our results suggest that ITGBL1 is a novel tumor suppressor in NSCLC progression.

Citing Articles

miR-576-5p Promotes the Proliferation of Papillary Thyroid Carcinoma through the MAPK4-AKT Pathway.

Hai R, Zhou Y, Li F, Guo Q, Long Y, Wang F Int J Anal Chem. 2023; 2022:1428411.

PMID: 36618768 PMC: 9815926. DOI: 10.1155/2022/1428411.


Small extracellular vesicles derived from dermal fibroblasts promote fibroblast activity and skin development through carrying miR-218 and ITGBL1.

Zou Q, Zhang M, Yuan R, Wang Y, Gong Z, Shi R J Nanobiotechnology. 2022; 20(1):296.

PMID: 35733144 PMC: 9215004. DOI: 10.1186/s12951-022-01499-2.


A comprehensive analysis of potential gastric cancer prognostic biomarker ITGBL1 associated with immune infiltration and epithelial-mesenchymal transition.

Wang Z, Fu L, Zhang J, Ge Y, Guo C, Wang R Biomed Eng Online. 2022; 21(1):30.

PMID: 35596183 PMC: 9123716. DOI: 10.1186/s12938-022-00998-5.


ITGBL1 transcriptionally inhibited by JDP2 promotes the development of pancreatic cancer through the TGF-beta/Smad pathway.

Du T, Zhang K, Zhang Z, Guo A, Yu G, Xu Y Braz J Med Biol Res. 2022; 55:e11989.

PMID: 35584452 PMC: 9113530. DOI: 10.1590/1414-431X2022e11989.


Integrin β-like 1 protein (ITGBL1) promotes cell migration by preferentially inhibiting integrin-ECM binding at the trailing edge.

Jang D, Kwon K, Song E, Park T Genes Genomics. 2022; 44(4):405-413.

PMID: 35066808 PMC: 8921176. DOI: 10.1007/s13258-021-01204-x.


References
1.
Tilman G, Mattiussi M, Brasseur F, van Baren N, Decottignies A . Human periostin gene expression in normal tissues, tumors and melanoma: evidences for periostin production by both stromal and melanoma cells. Mol Cancer. 2007; 6:80. PMC: 2222651. DOI: 10.1186/1476-4598-6-80. View

2.
Esposito V, Baldi A, De Luca A, Groger A, Loda M, GIORDANO G . Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer. Cancer Res. 1997; 57(16):3381-5. View

3.
Van Kouwenhove M, Kedde M, Agami R . MicroRNA regulation by RNA-binding proteins and its implications for cancer. Nat Rev Cancer. 2011; 11(9):644-56. DOI: 10.1038/nrc3107. View

4.
Lu P, Weaver V, Werb Z . The extracellular matrix: a dynamic niche in cancer progression. J Cell Biol. 2012; 196(4):395-406. PMC: 3283993. DOI: 10.1083/jcb.201102147. View

5.
Herbst R, Heymach J, Lippman S . Lung cancer. N Engl J Med. 2008; 359(13):1367-80. PMC: 10662965. DOI: 10.1056/NEJMra0802714. View